Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Compound Library

Anti-Ovarian Cancer Compound Library

Catalog No. L2196

Ovarian cancer is a malignant tumor that develops in the ovarian tissue. Approximately 90% to 95% of ovarian cancers are primary, meaning they form within the ovaries, while the remaining 5% to 10% are metastatic cancers that have spread to the ovaries from other sites. Early-stage ovarian cancer typically presents with no distinct symptoms, and even when symptoms are present, they lack specificity, making early diagnosis relatively challenging. About 60% to 70% of patients are diagnosed at an advanced stage with poor treatment outcomes. Although the occurrence of ovarian cancer is lower than that of cervical and endometrial cancers, its mortality rate is much higher. Ovarian cancer ranks as the leading cause of mortality among malignant tumors of the female reproductive tract, and mortality rate has been on the rise, posing a significant threat to women's health. Effectively improving the survival period of ovarian cancer patients has become a pressing challenge. In recent years, there has been remarkable progress in the development of molecular targeted therapies. It's shown that targeted drugs for the ovarian cancer play a significant role in enhancing patient survival. The development of targeted therapies has brought hope to ovarian cancer patients, offering them more effective treatment strategies. The TargetMol anti-ovarian cancer compound library comprises a collection of Xnum compounds, including compounds reported to exhibit therapeutic effects against ovarian cancer as well as compounds with the potential for treating ovarian cancer. The library serves as a valuable tool for the research and development of anti-ovarian cancer drugs.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Resource Download
Library compound info
Excel
SDF
Contact us for more batch information

Catalog No. L2196

Anti-Ovarian Cancer Compound Library

sizeIn stock

  • 1 mg
  • 30 μL x 10 mM (in DMSO)
  • 50 μL x 10 mM (in DMSO)
  • 100 μL x 10 mM (in DMSO)
  • 250 μL x 10 mM (in DMSO)
Inquiry & Custom

Top Publication Citing
Use of TargetMol Products

Cite scientific literature on TargetMol products

View More

Product Description Product Description

  • A unique collection of 2232 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;
  • Targets include PARP, VEGF, PD-1, HER2, etc;
  • Some compounds have already been launched or are in clinical phases.
  • Detailed compound information on structures, targets, IC50 and activity descriptions.
  • NMR and HPLC/LCMS validated to ensure high purity and quality.

Packaging And Storage | TargetMol Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice

Sci Citations

Library Customization | TargetMol Library Customization

Compound Library | TargetMol
Targetmol Compound Libraries
can be highly customized!
Inquiry & Custom

Library Customization | TargetMol Library Composition

Apoptosis
NF-κB
Autophagy
PI3K
EGFR
Reactive Oxygen Species
VEGFR
Wnt/beta-catenin
mTOR
p38 MAPK
Akt
ERK
Estrogen Receptor/ERR
PARP
Endogenous Metabolite
AMPK
GSK-3
Antibacterial
Raf
TGF-beta/Smad
CDK
PDGFR
MAPK
Estrogen/progestogen Receptor
JNK
Ras
IκB/IKK
MEK
TNF
FGFR
COX
c-Kit
FLT
Src
DNA-PK
NOD
RIP kinase
HER
S6 Kinase
Parasite
ATM/ATR
ALK
Antioxidant
Caspase
STAT
c-Met/HGFR
IL Receptor
PKC
IRAK
PDK
Antifungal
DNA/RNA Synthesis
Influenza Virus
Antibiotic
Ferroptosis
c-RET
Cytochromes P450
PPAR
Topoisomerase
Calcium Channel
HIV Protease
JAK
NO Synthase
PKA
Kras
PI4K
Rho
Aurora Kinase
Bcl-2 Family
Bcr-Abl
Casein Kinase
Nrf2
IGF-1R
Mitophagy
MMP
NOD-like Receptor (NLR)
ROS
Mitochondrial Metabolism
Chk
Dehydrogenase
FAK
Lipoxygenase
Microtubule Associated
MNK
p53
Potassium Channel
Tyrosine Kinases
AChR
c-Fms
HDAC
TLR
HCV Protease
HIF/HIF Prolyl-Hydroxylase
MLK
Virus Protease
Beta Amyloid
Epigenetic Reader Domain
GABA Receptor
HSP
NOS
PTEN
ROCK
Sodium Channel
Antiviral
Drug Metabolite
Interleukin
PDE
Phosphatase
SIK
Syk
TAM Receptor
Tyrosinase
5-HT Receptor
Antifection
Cholinesterase (ChE)
MELK
P-gp
Prostaglandin Receptor
Trk receptor
Anti-infection
ASK
E1/E2/E3 Enzyme
Ephrin Receptor
HIF
HSV
Tie-2
Transferase
TRP/TRPV Channel
Adrenergic Receptor
Aryl Hydrocarbon Receptor
ATPase
CaMK
Cannabinoid Receptor
Carbonic Anhydrase
c-Myc
DYRK
Free radical scavengers
GluR
GPR
GTPase
Histone Methyltransferase
Integrin
LDL
MAO
Opioid Receptor
Porcupine
Proteasome
RAAS
Serine Protease
Serine/threonin kinase
SGK
TOPK
BTK
Androgen Receptor
Aromatase
BACE
cAMP
CSF-1R
DNA Alkylation
DUB
Gamma-secretase
Glucosidase
HBV
Histamine Receptor
IAP
KLF
Mdm2
NADPH
PD-1/PD-L1
PGE Synthase
Pim
PLK
Progesterone Receptor
PROTACs
RANKL/RANK
Reductase
Reverse Transcriptase
S1P Receptor
transporter
ADC Cytotoxin
AAK1
ACK1
Acyltransferase
AhR
AIM2
Beta-Secretase
BMI-1
CCR
Chloride channel
DNA Alkylator/Crosslinker
Glucocorticoid Receptor
Glutathione Peroxidase
GST
IFNAR
Immunology/Inflammation related
IRE1
Leukotriene Receptor
Lipid
Liver X Receptor
LRRK2
LTR
MRP
MyD88
Myosin
NADPH-oxidase
NMDAR
Nucleoside Antimetabolite/Analog
PAI-1
PYK2
RAR/RXR
Retinoid Receptor
ROR
RSV
SARS-CoV
STING
Adenosine Deaminase
Adenosine Receptor
Adenylyl Cyclase
Aminopeptidase
Apelin receptor
Arginase
ATP Citrate Lyase
BCRP
CFTR
cGAS
Cholecystokinin Receptor
CRISPR/Cas9
CXCR
Cysteine Protease
DAPK
Decarboxylase
DHFR
Discoidin Domain Receptor (DDR)
Dopamine Receptor
FAAH
Fatty Acid Synthase
Glucokinase
Glutathione reductase
GNRH Receptor
gp120/CD4
GPX
Haspin Kinase
Hedgehog/Smoothened
Hippo pathway
Histone Acetyltransferase
Histone Demethylase
Hydroxylase
iGluR
Indoleamine 2,3-Dioxygenase (IDO)
Kinesin
Ligand for E3 Ligase
LIM Kinase
LPL Receptor
Methionine Adenosyltransferase (MAT)
MicroRNA
Monoamine Oxidase
Monoamine Transporter
Necroptosis
NPC1L1
OCT
OXPHOS
PAFR
PERK
Phospholipase
Phosphorylase
PKM
Platelet aggregation
Protease-activated Receptor
Proton pump
ROS Kinase
RXFP receptor
SGLT
Sirtuin
Smo
Somatostatin
Stemness kinase
VDA
Wee1
YAP

Keywords